Candriam SCA’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-3,511
Closed -$299K – 706
2023
Q3
$299K Hold
3,511
– – ﹤0.01% 645
2023
Q2
$383K Sell
3,511
-42,792
-92% -$4.06M ﹤0.01% 687
2023
Q1
$3.54M Buy
46,303
+38,811
+518% +$3.65M 0.02% 448
2022
Q4
$770K Sell
7,492
-2,045
-21% -$236K 0.01% 752
2022
Q3
$1.01M Sell
9,537
-54,900
-85% -$6.02M 0.01% 705
2022
Q2
$7.07M Buy
64,437
+25,641
+66% +$2.54M 0.06% 278
2022
Q1
$4.05M Buy
+38,796
New +$4.03M 0.03% 393

Other funds holding AMN

Candriam SCA's AMN Position: Q4 2023 in Review

Candriam SCA sold out of AMN Healthcare (AMN) in Q4 2023, closing a stake of 3,511 shares — an estimated $299K sold.

Candriam SCA first reported a position in AMN in Q1 2022 and held it in 7 quarters. The position peaked at $7.07M in Q2 2022. 381 funds tracked by Wall St. Rank hold AMN as of Q4 2023.

  • Candriam SCA reported no remaining AMN Healthcare position as of Q4 2023 after selling out during the quarter.
  • Candriam SCA sold 3,511 AMN Healthcare shares in Q4 2023, an estimated $299K.
  • Candriam SCA first reported a position in AMN Healthcare in Q1 2022 and held it in 7 quarters.
  • Candriam SCA's AMN Healthcare position peaked at $7.07M in Q2 2022.
  • 381 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2023.

Based on Candriam SCA's 13F filing for Q4 2023, filed 14 Feb 2024.